Perrigo Current Ratio 2010-2023 | PRGO
Perrigo Current Ratio Historical Data | |||
---|---|---|---|
Date | Current Assets | Current Liabilities | Current Ratio |
2023-12-31 | $2.83B | $1.59B | 1.79 |
2023-09-30 | $2.77B | $1.01B | 2.74 |
2023-06-30 | $2.77B | $1.06B | 2.62 |
2023-03-31 | $2.74B | $1.09B | 2.52 |
2022-12-31 | $2.72B | $1.11B | 2.44 |
2022-09-30 | $2.58B | $1.02B | 2.55 |
2022-06-30 | $2.65B | $1.02B | 2.61 |
2022-03-31 | $3.94B | $0.98B | 4.01 |
2021-12-31 | $3.86B | $1.59B | 2.43 |
2021-09-30 | $4.23B | $2.00B | 2.11 |
2021-06-30 | $4.42B | $1.99B | 2.23 |
2021-03-31 | $4.49B | $1.45B | 3.10 |
2020-12-31 | $3.13B | $1.38B | 2.27 |
2020-09-30 | $3.40B | $1.34B | 2.54 |
2020-06-30 | $3.80B | $1.86B | 2.05 |
2020-03-31 | $3.05B | $1.64B | 1.86 |
2019-12-31 | $2.73B | $1.34B | 2.04 |
2019-09-30 | $2.74B | $1.33B | 2.07 |
2019-06-30 | $3.44B | $1.79B | 1.92 |
2019-03-31 | $3.01B | $1.83B | 1.64 |
2018-12-31 | $2.90B | $1.54B | 1.89 |
2018-09-30 | $2.77B | $1.49B | 1.85 |
2018-06-30 | $2.78B | $1.54B | 1.81 |
2018-03-31 | $2.90B | $1.39B | 2.08 |
2017-12-31 | $2.82B | $1.44B | 1.96 |
2017-09-30 | $2.97B | $1.73B | 1.72 |
2017-06-30 | $2.82B | $1.63B | 1.73 |
2017-03-31 | $5.11B | $2.49B | 2.06 |
2016-12-31 | $2.81B | $1.84B | 1.53 |
2016-09-30 | $2.62B | $1.51B | 1.73 |
2016-06-30 | $3.03B | $2.06B | 1.47 |
2016-03-31 | $3.02B | $2.22B | 1.36 |
2015-12-31 | $2.79B | $2.55B | 1.09 |
2015-09-30 | $2.88B | $1.66B | 1.73 |
2015-06-30 | $3.18B | $1.69B | 1.88 |
2015-03-31 | $5.13B | $1.28B | 4.00 |
2014-12-31 | $5.36B | $1.33B | 4.05 |
2014-09-30 | $2.63B | $1.02B | 2.59 |
2014-06-30 | $2.55B | $1.08B | 2.37 |
2014-03-31 | $2.30B | $0.95B | 2.42 |
2013-12-31 | $2.29B | $0.96B | 2.38 |
2013-09-30 | $2.37B | $0.74B | 3.18 |
2013-06-30 | $2.24B | $0.75B | 2.99 |
2013-03-31 | $1.70B | $0.67B | 2.52 |
2012-12-31 | $1.77B | $0.64B | 2.79 |
2012-09-30 | $1.90B | $0.63B | 3.02 |
2012-06-30 | $1.80B | $0.65B | 2.75 |
2012-03-31 | $1.79B | $0.63B | 2.84 |
2011-12-31 | $1.73B | $0.67B | 2.60 |
2011-09-30 | $1.30B | $0.62B | 2.09 |
2011-06-30 | $1.38B | $0.61B | 2.27 |
2011-03-31 | $1.26B | $0.57B | 2.22 |
2010-12-31 | $1.16B | $0.59B | 1.98 |
2010-09-30 | $1.02B | $0.57B | 1.78 |
2010-06-30 | $1.40B | $0.92B | 1.52 |
2010-03-31 | $1.15B | $0.45B | 2.53 |
2009-12-31 | $1.16B | $0.49B | 2.39 |
2009-09-30 | $1.10B | $0.46B | 2.40 |
2009-06-30 | $1.15B | $0.50B | 2.30 |
2009-03-31 | $1.04B | $0.44B | 2.37 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $4.263B | $4.656B |
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $196.909B | 25.56 |
Stryker (SYK) | United States | $136.478B | 33.84 |
Medtronic (MDT) | Ireland | $115.414B | 16.34 |
EssilorLuxottica (ESLOY) | France | $103.810B | 0.00 |
Boston Scientific (BSX) | United States | $100.864B | 33.47 |
Lonza Group Ag (LZAGY) | Switzerland | $44.257B | 0.00 |
Haleon (HLN) | United Kingdom | $39.385B | 30.46 |
ResMed (RMD) | United States | $28.878B | 28.87 |
Terumo (TRUMY) | Japan | $27.930B | 39.32 |
Zimmer Biomet Holdings (ZBH) | United States | $27.196B | 17.54 |
Baxter (BAX) | United States | $21.679B | 15.81 |
Koninklijke Philips (PHG) | Netherlands | $18.879B | 15.06 |
Insulet (PODD) | United States | $11.830B | 62.20 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.515B | 0.00 |
Demant (WILYY) | Denmark | $11.278B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.969B | 29.70 |
BellRing Brands (BRBR) | United States | $7.702B | 41.41 |
Haemonetics (HAE) | United States | $4.271B | 21.84 |
GN Store Nord (GNNDY) | Denmark | $4.150B | 26.87 |
Lantheus Holdings (LNTH) | United States | $4.145B | 10.70 |
Envista Holdings (NVST) | United States | $3.697B | 14.09 |
Prestige Consumer Healthcare (PBH) | United States | $3.606B | 17.05 |
Neogen (NEOG) | United States | $3.347B | 32.21 |
QuidelOrtho (QDEL) | United States | $3.226B | 11.71 |
Green Thumb Industries (GTBIF) | United States | $3.155B | 100.00 |
ICU Medical (ICUI) | United States | $2.484B | 18.71 |
TG Therapeutics (TGTX) | United States | $2.404B | 778.50 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.157B | 0.00 |
Verano Holdings (VRNOF) | United States | $2.151B | 0.00 |
Owens & Minor (OMI) | United States | $2.141B | 20.55 |
InMode (INMD) | Israel | $1.780B | 9.22 |
National Vision Holdings (EYE) | United States | $1.720B | 53.56 |
Agios Pharmaceuticals (AGIO) | United States | $1.636B | 0.00 |
AdaptHealth (AHCO) | United States | $1.510B | 11.36 |
LeMaitre Vascular (LMAT) | United States | $1.499B | 49.78 |
AtriCure (ATRC) | United States | $1.458B | 0.00 |
Warby Parker (WRBY) | United States | $1.303B | 0.00 |
MacroGenics (MGNX) | United States | $0.934B | 0.00 |
Quanterix (QTRX) | United States | $0.873B | 0.00 |
Canopy Growth (CGC) | Canada | $0.870B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.836B | 0.00 |
Evolus (EOLS) | United States | $0.811B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.771B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.716B | 15.47 |
TerrAscend (TSNDF) | Canada | $0.571B | 0.00 |
Valneva SE (VALN) | France | $0.553B | 0.00 |
Jin Medical (ZJYL) | China | $0.543B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.529B | 11.46 |
PetIQ (PETQ) | United States | $0.513B | 19.17 |
OraSure Technologies (OSUR) | United States | $0.470B | 7.77 |
ZimVie (ZIMV) | United States | $0.442B | 27.18 |
Biote (BTMD) | United States | $0.438B | 4.16 |
Surmodics (SRDX) | United States | $0.410B | 44.31 |
Zynex (ZYXI) | United States | $0.405B | 46.59 |
Viemed Healthcare (VMD) | United States | $0.364B | 36.08 |
Cerus (CERS) | United States | $0.325B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.322B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.259B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.252B | 15.36 |
TriSalus Life Sciences (TLSI) | United States | $0.248B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.216B | 0.00 |
Omeros (OMER) | United States | $0.215B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.213B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.189B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.183B | 0.00 |
High Tide (HITI) | Canada | $0.163B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.146B | 0.00 |
Fonar (FONR) | United States | $0.138B | 11.84 |
InterCure (INCR) | Israel | $0.115B | 19.46 |
Societal CDMO (SCTL) | United States | $0.115B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.114B | 0.00 |
FitLife Brands (FTLF) | United States | $0.106B | 20.70 |
MariMed (MRMD) | United States | $0.102B | 0.00 |
Safety Shot (SHOT) | United States | $0.094B | 0.00 |
Chimerix (CMRX) | United States | $0.090B | 0.00 |
Veru (VERU) | United States | $0.089B | 0.00 |
Brainsway (BWAY) | Israel | $0.087B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.084B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.080B | 43.99 |
Zevia PBC (ZVIA) | United States | $0.075B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.065B | 4.25 |
Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
Apyx Medical (APYX) | United States | $0.049B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
Bright Green (BGXX) | United States | $0.047B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.045B | 0.00 |
Modular Medical (MODD) | United States | $0.043B | 0.00 |
ImmuCell (ICCC) | United States | $0.041B | 0.00 |
United-Guardian (UG) | United States | $0.036B | 13.85 |
FSD PHARMA (HUGE) | Canada | $0.028B | 0.00 |
Agape ATP (ATPC) | $0.027B | 0.00 | |
Exagen (XGN) | United States | $0.027B | 0.00 |
Nephros (NEPH) | United States | $0.024B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.020B | 0.00 |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
ProSomnus (OSA) | United States | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
GlucoTrack (GCTK) | United States | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |